ArticleJournal of neuro-oncology2021

Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR.

Kedar S Vaidya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.